Product Information
FT ANTACID EX-STR 750 MG CHEW is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.0315 per EA under NDC 70677107601. Its NADAC has been published 152 times since Nov 8, 2023.
Strength
750 mg/1
Manufacturer
Strategic Sourcing Services LLCNDC
70677107601
Classification
Generic
Dosage Form
TABLET, CHEWABLE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CALCIUM CARBONATEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M001On Market Since
7/12/2023
Pharmacological Classes
Price Statistics
The NADAC for FT ANTACID EX-STR 750 MG CHEW has been published 152 times since Nov 8, 2023, and over the history we have for it it has risen 12.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0315 per EA |
|---|---|
| All-time high | $0.0330 (Nov 13, 2024) |
| All-time low | $0.0263 (Jan 17, 2024) |
| 52-week high | $0.0325 |
| 52-week low | $0.0311 |
| Median price | $0.0319 |
| Average price | $0.0313 |
| Largest weekly change | -11.2% (Jan 17, 2024) |
| Weeks tracked | 152 |
| Tracking since | Nov 8, 2023 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strategic Sourcing Services LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Calcium carbonate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Blood Coagulation Factor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FT ANTACID EX-STR 750 MG CHEW?
The current National Average Drug Acquisition Cost (NADAC) for FT ANTACID EX-STR 750 MG CHEW, manufactured by Strategic Sourcing Services LLC, is $0.0315 per EA (NDC 70677107601), effective Sep 30, 2026.
How has the price of FT ANTACID EX-STR 750 MG CHEW changed over time?
Over the history we have for it, the NADAC for FT ANTACID EX-STR 750 MG CHEW has risen 12.7%. It has been tracked across 152 weekly CMS publications since Nov 8, 2023.
What are the highest and lowest recorded NADAC prices for FT ANTACID EX-STR 750 MG CHEW?
Since Nov 8, 2023, the NADAC for FT ANTACID EX-STR 750 MG CHEW has ranged from a low of $0.0263 (Jan 17, 2024) to a high of $0.0330 (Nov 13, 2024), with a median of $0.0319 per EA.
Are there cheaper alternatives to FT ANTACID EX-STR 750 MG CHEW?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FT ANTACID EX-STR 750 MG CHEW in a comparable dosage form, but none are currently priced below it.
Who manufactures FT ANTACID EX-STR 750 MG CHEW?
FT ANTACID EX-STR 750 MG CHEW (NDC 70677107601) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.